Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (461-470 of 681) with videos related to

Pageof 69
Sort By:
AIDS (London, England)|August 16, 2013
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkersÁlvaro H Borges, Michael J Silverberg, Deborah Wentworth, et al.
HIV Medicine|February 26, 2015
Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialS Sharma, A G Babiker, S Emery, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across EuropeWendy P Bannister, Ole Kirk, Jose M Gatell, et al.
AIDS (London, England)|September 22, 2007
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitorsZoe V Fox, Anna Maria Geretti, Jesper Kjaer, et al.
AIDS (London, England)|January 16, 2008
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDAWendy P Bannister, Lidia Ruiz, Alessandro Cozzi-Lepri, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trialsUlrik S Justesen, Zoe Fox, Court Pedersen, et al.
Transplantation Direct|August 21, 2018
Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell TransplantationIsabelle P Lodding, Amanda Mocroft, Caspar da Cunha Bang, et al.
Open Forum Infectious Diseases|June 8, 2018
Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell TransplantationI P Lodding, C da Cunha Bang, S S Sørensen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2012
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunctionJason V Baker, Jacqueline Neuhaus, Daniel Duprez, et al.
Lancet (London, England)|December 16, 1998
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study GroupA Mocroft, S Vella, T L Benfield, et al.
Pageof 69

Showing results (461-470 of 681) with videos related to

Sort By:
Pageof 69
AIDS (London, England)|August 16, 2013
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkersÁlvaro H Borges, Michael J Silverberg, Deborah Wentworth, et al.
HIV Medicine|February 26, 2015
Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialS Sharma, A G Babiker, S Emery, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across EuropeWendy P Bannister, Ole Kirk, Jose M Gatell, et al.
AIDS (London, England)|September 22, 2007
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitorsZoe V Fox, Anna Maria Geretti, Jesper Kjaer, et al.
AIDS (London, England)|January 16, 2008
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDAWendy P Bannister, Lidia Ruiz, Alessandro Cozzi-Lepri, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trialsUlrik S Justesen, Zoe Fox, Court Pedersen, et al.
Transplantation Direct|August 21, 2018
Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell TransplantationIsabelle P Lodding, Amanda Mocroft, Caspar da Cunha Bang, et al.
Open Forum Infectious Diseases|June 8, 2018
Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell TransplantationI P Lodding, C da Cunha Bang, S S Sørensen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2012
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunctionJason V Baker, Jacqueline Neuhaus, Daniel Duprez, et al.
Lancet (London, England)|December 16, 1998
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study GroupA Mocroft, S Vella, T L Benfield, et al.
Pageof 69